How interferon-γ keeps autoimmune diseases in check
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 29 (10) , 479-486
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector categoryJournal of Experimental Medicine, 2008
- Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-γClinical Immunology, 2008
- Altered Chemokine Profile Associated with Exacerbated Autoimmune Pathology under Conditions of Genetic Interferon-γ DeficiencyInvestigative Ophthalmology & Visual Science, 2007
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activationJournal of Clinical Investigation, 2007
- Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitisBritish Journal of Ophthalmology, 2006
- Role of IFN-g in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ TregsJournal of Clinical Investigation, 2006
- T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17Journal of Experimental Medicine, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006